Hepatocytes of double-transgenic mice expressing high levels of hepatitis B virus e antigen and interferon-γ are not injured by HBeAg specific autoantibodies

Archives of Virology

Volumn 145, Issue 6, 2000, Pages 1081-1098

  Merkle, H ^a   Nusser, P ^a   Knehr, S ^a   Lohler J ^b   Barsig, J ^a   Yamamura, K I ^d   Reifenberg, K ^c  

^a UNIVERSITY OF ULM   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Institute of Molecular Embryology and Genetics   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANTIBODY SPECIFICITY; AUTOANTIBODY; CELL SECRETION; GAMMA INTERFERON; HEPATITIS B VIRUS; LIVER CELL; MACROPHAGE; PATHOGENICITY; SEROCONVERSION; TRANSGENIC MOUSE; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN; VIRUS INFECTION;

ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CELL LINE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; INTERFERON TYPE II; INTERFERON-ALPHA; LIVER; MICE; MICE, TRANSGENIC; PROTEIN PRECURSORS; TRANSFECTION; VIRAL CORE PROTEINS;

ALPHAVIRUS; ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 0033923307     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050070111     Document Type: Article

References (48)

1. 1. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang SN, Chisari FV (1993) Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 178: 1 541-1 554
2. 2. Bortolotti F, Cadrobbi P, Crivellaro C, Alberti A, Rugge M, Bertaggia A, Realdi G (1983) Changes in hepatitis Be antigen/antibody system in children with chronic hepatitis B virus infection. J Pediatr 103: 718-722
3. 3. Chang C, Enders G, Sprengel R, Peters N, Varmus H, Ganem D (1987) Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol 61: 3 322-3 325
4. 4. Chisari FV, Ferrari C (1995) Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13: 29-60
5. 5. Colgrove R, Simon G, Ganem D (1989) Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol 63: 4 019-4 026
6. 6. Diepolder HM, Ries G, Jung MC, Schlicht HJ, Gerlach JT, Grunner N, Caselmann WH, Pape GR (1999) Differential antigen-processing pathways of the hapatitis B virus e and core proteins. Gastroenterology 116: 650-657
7. 7. Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, Petit MA, Fiaccadori F (1990) Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 145: 3 442-3 449
8. 8. Garcia P, Ou J, Rutter W, Walter P (1988) Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol 106: 1 093-2 004
9. 9. Gilles PN, Guerrette DL, Ulevitch RJ, Schreiber RD, Chisari FV (1992) HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma. Hepatology 16: 655-663
10. 10. Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA (1983) Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus. Hepatology 3: 656-662
11. 11. Heise T, Guidotti LG, Chisari FV (1999) La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA. J Virol 73: 5 767-5 776
12. 12. Heise T, Guidotti LG, Cavanaugh VJ, Chisari FV (1999) Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol 73: 474-481
13. 13. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB (1981) Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Int Med 94: 744-748
14. 14. Hoofnagle JH, Di Bisceglie AM (1991) Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis 11: 73-83
15. 15. Huang J, Liang TJ (1993) A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol Cell Biol 13: 7 476-7 486
16. 16. Jung MC, Diepolder HM, Spengler U, Wierenga EA, Zachoval R, Hoffmann RM, Eichenlaub D, Frosner G, Will H, Pape GR (1995) Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol 69: 3 358-3 368
17. 17. Klaunig JE, Goldblatt PJ, Hinton DE, Lipsky MM, Trump BF (1981) Mouse liver cell culture I. Hepatocyte isolation. In vitro 17: 913-925
18. 18. Kuhrober A, Pudollek HP, Reifenberg K, Chisari FV, Schlicht HJ, Reimann J, Schirmbeck R (1996) DNA immunization induces antibody and cytotoxic T cell response to hepatitis B core antigen in H-2b mice. J Immunol 156: 3 687-3 695
19. 19. Kuhrober A, Wild J Pudollek HP, Chisari FV, Reimann J (1997) DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Int Immunol 9: 1 203-1 212
20. 20. Lavine JE, Bull FG, Millward-Sadler G, Arthur MJP (1992) Acute viral hepatitis. In: Millward-Sadler G, Wright R, Arthur MJP (eds) Wright's liver and biliary disease. WB Saunders, London, pp 679-786
21. 21. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A (1994) Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 154: 1 778-1 788
22. 22. Magnius LO, Espmark JA (1972) New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol 109: 1 017-1 021
23. 23. Milich DR, Jones J, Hughes J, Price J, Raney A, and McLachlan A (1990) Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 87: 6 599-6 603
24. 24. Milich DR, McLachlan A, Raney AK, Houghten R, Thornton GB, Maruyama T, Hughes JL, Jones JE (1991) Autoantibody production in hepatitis B e antigen transgenic mice elicited with a self T-cell peptide and inhibited with nonself peptides. Proc Natl Acad Sci USA 88: 4 348-4 352
25. 25. Milich DR, Schodel F, Peterson DL, Jones JE, Hughes JL (1995) Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur J Immunol 25: 1 663-1 672
26. 26. Milich DR, Wolf SF, Hughes JL, Jones JE (1995) Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice. Proc Natl Acad Sci USA 92: 6 847-6 851
27. 27. Milich DR, Schodel F, Hughes JL, Jones JE, and Peterson DL (1997) The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol 71: 2 192-2 201
28. 28. Milich DR, Chen MK, Hughes JL, Jones JE (1998) The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 160: 2 013-2 021
29. 29. Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, Ferrari C, Chisari FV (1993) HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 177: 751-762
30. 30. Nassal M, Junker-Niepmann, Schaller H (1990) Translational inactivation of RNA function: discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly. Cell 63: 1 357-1 363
31. 31. Okamoto T, Furuya M, Yamakawa T, Yamamura K, Hino O (1996) TNF-alpha gene expression in the liver of the IFN-gamma transgenic mouse with chronic active hepatitis. Biochem Biophys Res Commun 226: 762-768
32. 32. Ou J, Laub O, Rutter W (1986) Hepatitis B virus gene function: The precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci USA 83: 1 578-1 582
33. 33. Realdi G, Alberti A, Rugge M, Bortolotti F, Rigoli AM, Tremolada F, Ruol A (1980) Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 79: 195-199
34. b mice in utero, Virology 243: 45-53
35. 35. Reifenberg K, Wilts H, Lohler J, Nusser P, Hanano R, Guidotti LG, Chisari FV, Schlicht HJ (1999) The hepatitis B virus X protein transactivates viral core gene expression in vivo. J Virol 73: 10 399-10 405
36. 36. Ro HS, Xu L (1991) Nucleotide sequences of a cDNA clone encoding mouse ribosomal protein S24. Nucleic Acids Res 19: 6 647
37. 37. Romero R, Lavine JE (1996) Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 23: 17-23
38. 38. Schlicht HJ, Salfeld J, Schaller H (1987) The pre-C region of the duck hepatitis B virus encodes a signal sequence which is essential for the synthesis and secretion of processed core proteins but not for virus formation. J Virol 61: 3 701-3 709
39. 39. Schlicht HJ, Schaller H (1989) The secretory core protein of human hepatitis B virus is expressed on the cell surface. J Virol 63: 5 399-5 404
40. 40. Scullard GH, Pollard RB, Smith JL, Sacks SL, Gregory PB, Robinson WS, Merigan TC (1981) Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis 143: 772-783
41. 41. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, Mc Kenna S, Mobrnaten L, Rajan TV, Greiner DL (1995) Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154: 180-191
42. 42. Stephen W, Prince AM, Brotman B (1984) Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen. J Virol 51: 420-424
43. 43. Townsend K, Sallberg M, O'Dea J, Banks T, Driver D, Sauter S, Chang S, MJolly DJ, Mento SJ, Milich DR, Lee WT (1997) Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens. J Virol 71: 3 365-3 374
44. 44. Toyonaga T, Hino O, Sugai S, Wakasugi S, Abe K, Shichiri M, Yamamura K (1994) Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci USA 91: 614-618
45. 45. Tsui L, Guidotti G, Ishikawa T, Chisari FV (1995) Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc Natl Acad Sci USA 92: 12 398-12 402
46. 46. Yared G, Hussain KB, Nathani MG, Moshier JA, Dosescu J, Mutchnick MG, Naylor PH (1998) Cytokine-mediated apoptosis and inhibition of virus production and anchorage independent growth of viral transfected hepatoblastoma cells. Cytokine 10: 586-595
47. 47. Yu X, Mertz JE (1996) Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated. J Virol 70: 8 719-8 726
48. 48. Yu X, Mertz JE (1997) Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily. J Virol 71: 9 366-9 374